Allspring Global Investments Holdings, LLC Collegium Pharmaceutical, Inc Transaction History

Allspring Global Investments Holdings, LLC

$53.9 Billion
Q1 2025

A detailed history of Allspring Global Investments Holdings, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 8,180 shares of COLL stock, worth $240,001. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,180

Holding current value

$240,001

% of portfolio

0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 24, 2025	BUY	$28.04 - $33.91 $229,367 - $277,383	8,180 New	8,180 $244,000
Q3 2024 Oct 18, 2024	BUY	$31.4 - $39.07 $1.14 Million - $1.42 Million	36,331 Added 83.54%	79,822 $3.08 Million
Q2 2024 Jul 26, 2024	SELL	$31.36 - $39.99 $61,057 - $77,860	-1,947 Reduced 4.28%	43,491 $1.4 Million
Q1 2024 Apr 18, 2024	SELL	$31.23 - $40.91 $13,241 - $17,345	-424 Reduced 0.92%	45,438 $1.76 Million
Q4 2023 Jan 25, 2024	BUY	$21.16 - $30.8 $88,702 - $129,113	4,192 Added 10.06%	45,862 $1.41 Million
Q3 2023 Oct 27, 2023	BUY	$21.23 - $24.28 $884,654 - $1.01 Million	41,670 New	41,670 $931,000
Q2 2023 Jul 18, 2023	BUY	$21.06 - $24.0 $24,892 - $28,368	1,182 Added 46.5%	3,724 $80,000
Q1 2023 Apr 13, 2023	BUY	$23.0 - $29.88 $13,363 - $17,360	581 Added 29.63%	2,542 $60,000
Q4 2022 Jan 23, 2023	SELL	$16.14 - $23.55 $694 - $1,012	-43 Reduced 2.15%	1,961 $0
Q3 2022 Oct 26, 2022	BUY	$15.46 - $20.1 $3,787 - $4,924	245 Added 13.93%	2,004 $32,000
Q2 2022 Jul 25, 2022	SELL	$14.22 - $20.88 $912,326 - $1.34 Million	-64,158 Reduced 97.33%	1,759 $31,000
Q1 2022 May 02, 2022	SELL	$17.2 - $22.5 $260,442 - $340,695	-15,142 Reduced 18.68%	65,917 $1.34 Million
Q4 2021 Jan 28, 2022	BUY	$17.5 - $21.35 $1.42 Million - $1.73 Million	81,059 New	81,059 $1.51 Million

Others Institutions Holding COLL

# of Institutions

253

Shares Held

37.1M

Call Options Held

61.1K

Put Options Held

5.8K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account

Allspring Global Investments Holdings, LLC Collegium Pharmaceutical, Inc Transaction History